Patents by Inventor Siew C. Schleyer

Siew C. Schleyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
    Patent number: 7476506
    Abstract: This invention relates to compositions and uses of NRG4, and to variants thereof and to polynucleotides encoding NRG4, for therapeutic and diagnostic purposes, particularly related to colon and pancreatic cancer. This invention also relates to therapeutic agents based on or derived from the polynucleotides and proteins, NRG4 inhibitors, particularly antibodies capable of specifically binding to NRG4.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: January 13, 2009
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Siew C. Schleyer, Anne B. Jefferson, Judith A. Abraham, W. Michael Kavanaugh
  • Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
    Patent number: 7198899
    Abstract: This invention relates to compositions and uses of NRG4, and to variants thereof and to polynucleotides encoding NRG4, for therapeutic and diagnostic purposes, particularly related to colon and pancreatic cancer. This invention also relates to therapeutic agents based on or derived from the polynucleotides and proteins, NRG4 inhibitors, particularly antibodies capable of specifically binding to NRG4.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: April 3, 2007
    Assignee: Chiron Corporation
    Inventors: Siew C. Schleyer, Anne B. Jefferson, Judith A. Abraham, W. Michael Kavanaugh
  • Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
    Publication number: 20040005622
    Abstract: This invention relates to compositions and uses of NRG4, and to variants thereof and to polynucleotides encoding NRG4, for therapeutic and diagnostic purposes, particularly related to colon and pancreatic cancer. This invention also relates to therapeutic agents based on or derived from the polynucleotides and proteins, NRG4 inhibitors, particularly antibodies capable of specifically binding to NRG4.
    Type: Application
    Filed: June 3, 2003
    Publication date: January 8, 2004
    Applicant: Chiron Corporation
    Inventors: Siew C. Schleyer, Anne B. Jefferson, Judith A. Abraham, W. Michael Kavanaugh